Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial

Early short-term intensive insulin (STII) therapy can induce drug-free glycemic remission for up to 1 year in half of newly diagnosed type 2 diabetic mellitus (T2DM) patients. Whether exenatide following STII therapy will induce higher long-term glycaemic remission is currently unknown. To assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiulin, Shi, Yalin, Chen, Ning, Lin, Mingzhu, Su, Weijuan, Zhang, Huijie, Liu, Changqin, Song, Haiqu, Xiao, Fangsen, Huang, Peiying, Wang, Liying, Liu, Wei, Zeng, Jinyang, Yan, Bing, Liu, Qi, Liu, Suhuan, Yang, Shuyu, Li, Xiaoying, Li, Zhibin, Li, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443840/
https://www.ncbi.nlm.nih.gov/pubmed/28539618
http://dx.doi.org/10.1038/s41598-017-02631-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443840/
https://www.ncbi.nlm.nih.gov/pubmed/28539618
http://dx.doi.org/10.1038/s41598-017-02631-1

Ejemplares similares